Close
Close

Maslimomab (CAT#: TAB-248)

Datasheet
DESCRIPTION CATALOG # SIZE PRICE
Anti-Human T-cell receptor Recombinant Antibody TAB-248 1mg Please Inquiry

PRODUCT INFORMATION

  • Product Overview
  • Recombinant monoclonal antibody to T-cell receptor. Maslimomab is a mouse monoclonal antibody and an immunosuppressive drug.
  • Target
  • T-cell receptor
  • Type
  • IgG2b
  • Immunogen
  • Thymus, spleen and mesenteric lymph nodes isolated from a mouse transgenic for human Vb3 TcR.
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Applications
  • Suitable for use in WB, ELISA, IP, FC, FuncS, Neut, IF and most other immunological methods.
  • CAS
  • 127757-92-0
  • Specific Activity
  • Tested positive against native human antigen.
  • Protein Construction
  • Immunoglobulin G2b,anti-(human TCR ab(receptor)) (mouse monoclonal g2b-chain), disulfide with mouse monoclonal, dimer (9CI)
  • Purity
  • >95.0% as determined by analysis by RP-HPLC.
  • Size
  • 1mg
  • Storage
  • At -20°C for one year.

BACKGROUND

  • Introduction
  • Monoclonal antibody and an immunosuppressive drug.
  • Antigen Description
  • The T cell receptor or TCR is a molecule found on the surface of T lymphocytes (or T cells) that is responsible for recognizing antigens bound to major histocompatibility complex (MHC) molecules. The binding between TCR and antigen is of relatively low affinity and is degenerate: that is, many TCR recognize the same antigen and many antigens are recognized by the same TCR.
  • Keywords
  • T cell receptor alpha locus; TCRA; TRA; TCRD; T-cell antigen receptor, alpha polypeptide; T-cell receptor, alpha (V,D,J,C); TRA@
  • Synonyms
  • T cell receptor alpha locus; TCRA; TRA; TCRD; T-cell antigen receptor, alpha polypeptide; T-cell receptor, alpha (V,D,J,C); TRA@

Customer reviews and Q&As    

Related Products
Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2024 Creative Biolabs. | Contact Us